Abstract:
A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2:59-84, Al2O3:7-18.5, CaO:1-25, SrO:0-6.5, BaO:0-5, ZrO2:0-3, TiO2:0-5, B2O3:0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3
Abstract:
A glass tube for pharmaceutical containers and a process for the production of a glass tube are provided. The glass tubes have low alkali leachability and are devoid of a lamp ring.
Abstract:
A method for producing glass vials, in particular pharmaceutical vials or pharmaceutical ampoules, from a glass tube is provided, the method including the following steps: (a) rotating the glass tube about a longitudinal axis thereof; (b) locally heating the glass tube from one side by means of at least one burner to at least the softening temperature of the glass; (c) reducing the diameter by pressing at least one forming body laterally against the heated region; and (d) separating the glass tube by means of a burner. A glass vial produced in such a way releases a reduced amount of alkali in accordance with ISO 4802 and has a decreased delamination tendency. Furthermore, in the hot-formed peripheral region, the alkali content is only slightly reduced when compared with the alkali content in the glass interior.
Abstract:
A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2: 5 9-84, Al2O3: 7-18.5, CaO: 1-25, SrO: 0-6.5, BaO: 0-5, ZrO2: 0-3, TiO2: 0-5, B2O3: 0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3
Abstract:
An apparatus for forming glass tubes is provided. The apparatus includes a Danner-pipe, a heating device, and a heating chamber having the Danner-pipe and the heating device arranged therein. The Danner-pipe is inclined with respect to a horizontal plane by a Danner-angle. The heating device is inclined with respect to the horizontal plane by a heating-angle. The Danner-angle and/or the heating angle are in a range of 1° to 45°.
Abstract:
Borosilicate glasses, preferably for use in the pharmaceutical sector, are provided. The borosilicate glasses are outstandingly suitable for the use as pharmaceutical primary packaging, such as phials or ampoules, since the aqueous or water-containing medicaments kept in the containers do not attack the glass significantly, and so the glass releases no, or only few, ions. The borosilicate glasses have the following composition in % by weight or consist thereof: SiO271-77; B2O39-12; Al2O35.5-8; Na2O6-8; K2O0.1-0.9; Li2O0-0.3; CaO0-1.5; BaO0-1; F0-0.3; Cl-0-0.3; and MgO + CaO + BaO + SrO 0-2.
Abstract translation:提供优选用于制药领域的硼硅酸盐玻璃。 硼硅酸盐玻璃非常适合用作药物初级包装,例如药瓶或安瓿,因为保持在容器中的含水或含水药物不会显着地侵蚀玻璃,因此玻璃不会释放出或仅少量的, 离子。 硼硅酸盐玻璃具有以重量%计的以下组成或其组成:SiO 2 71-77; B2O3 9-12; Al2O3 5.5-8; Na2O 6-8; K2O 0.1-0.9; Li2O 0-0.3; CaO 0-1.5; BaO 0-1; F 0-0.3; Cl- 0-0.3; 和MgO + CaO + BaO + SrO 0-2。
Abstract:
A glass tube has a center axis, where for the glass tube a specific cross-sectional plane is defined which includes the center axis and which is parallel to the center axis. Within the specific cross-sectional plane, for each pair of outer diameters d1 and d2 of the glass tube at any two arbitrarily selected first axial position x1 and second axial positions x2 along the center axis, respectively, the following relation is 60 or smaller: |(d2−d1)/(x2−x1)|*(10{circumflex over ( )}6 mm)/d1.
Abstract:
An apparatus for forming glass tubes is provided. The apparatus includes a Danner-pipe, a heating device, and a heating chamber having the Danner-pipe and the heating device arranged therein. The Danner-pipe is inclined with respect to a horizontal plane by a Danner-angle. The heating device is inclined with respect to the horizontal plane by a heating-angle. The Danner-angle and/or the heating angle are in a range of 1° to 45°.
Abstract:
A method for producing glass vials, in particular pharmaceutical vials or pharmaceutical ampoules, from a glass tube is provided, the method including the following steps: (a) rotating the glass tube about a longitudinal axis thereof; (b) locally heating the glass tube from one side by means of at least one burner to at least the softening temperature of the glass; (c) reducing the diameter by pressing at least one forming body laterally against the heated region; and (d) separating the glass tube by means of a burner. A glass vial produced in such a way releases a reduced amount of alkali in accordance with ISO 4802 and has a decreased delamination tendency. Furthermore, in the hot-formed peripheral region, the alkali content is only slightly reduced when compared with the alkali content in the glass interior.
Abstract:
A zirconium-free neutral glass is provided that finds use in the pharmaceutical sector. The glass has a combination of alkali metal oxides of sodium, potassium and optionally lithium, and a controlled amount of aluminum oxide, which provides a zirconium-free and low-boron neutral glass having good hydrolytic stability, good acid and alkali stability and good devitrification properties. The glass includes the following components in % by weight: SiO2 72-82, B2O3 3-8, Al2O3 5-8, Na2O2.5-5.5, K2O3.6-8.4, Li2O 0-0.7, MgO 0-0.7, CaO 0-0.4, and TiO2 0-5, wherein Li2O + Na2O + K2O6.8-14.6, and K2O/Na2O ratio0.7-3.4.